Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsPOWDER, FOR SOLUTIONStandard

LETYBO

LETIBOTULINUMTOXINA-WLBG

Standard Dose
0.1ML(4UNITS)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview LETYBO is listed in Drugs@FDA under application 761225 (BLA).

Review priority: STANDARD Marketing status: Prescription Active ingredient LETIBOTULINUMTOXINA-WLBG Form and strength POWDER, FOR SOLUTION - 0.1ML(4UNITS) Sponsor HUGEL INC Submission history Latest submission status date: 2024-02-29 00:00:00.

Structured Monograph

Clinical summary

Approval overview LETYBO is listed in Drugs@FDA under application 761225 (BLA). Review priority: STANDARD Marketing status: Prescription Active ingredient LETIBOTULINUMTOXINA-WLBG Form and strength POWDER, FOR SOLUTION - 0.1ML(4UNITS) Sponsor HUGEL INC Submission history Latest submission status date: 2024-02-29 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.